| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 164,758 | 144,201 | 167,400 | 179,654 | | Cost of Revenue | 90,093 | 83,481 | 95,557 | 98,523 | | | Gross Profit | 74,665 | 60,720 | 71,843 | 81,131 | | | Operating Expenses | | Research Development | 44,442 | 49,482 | 46,700 | 47,142 | | Selling General and Administrative | 42,992 | 45,910 | 45,404 | 54,982 | | Non Recurring | 3,941 | 462,072 | 76 | 1,110 | | Others | 6,224 | 6,224 | 6,404 | 8,363 | | | | Total Operating Expenses | 97,599 | 563,688 | 98,584 | 111,597 | | | | Operating Income or Loss | (22,934) | (502,968) | (26,741) | (30,466) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,194) | 938 | 4,095 | 4,796 | | Earnings Before Interest And Taxes | (24,128) | (502,030) | (22,646) | (25,670) | | Interest Expense | 1,856 | 1,852 | 1,844 | 1,853 | | Income Before Tax | (25,984) | (503,882) | (24,490) | (27,523) | | Income Tax Expense | 470 | (672) | 341 | (2,127) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (26,454) | (503,210) | (24,831) | (25,396) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (26,454) | (503,210) | (24,831) | (25,396) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($26,454) | ($503,210) | ($24,831) | ($25,396) |
|
0.17% Nasdaq 
Income Statement
